Background: The reported risk of hypomagnesemia in patients with proton pump inhibitor
(PPI) use is conflicting. The objective of this meta-analysis was to assess the association …

Background: Previous meta-analyses have suggested that there might be an association
between the use of proton pump inhibitors (PPIs) and the development of hypomagnesemia …

Proton pump inhibitors (PPIs), long thought to be safe, are associated with a number of
nonkidney adverse health outcomes and several untoward kidney outcomes, including …

Background Although many case reports have described patients with proton pump inhibitor
(PPI)-induced hypomagnesemia, the impact of PPI use on hypomagnesemia has not been …

Background Proton pump inhibitor (PPI) use has been associated with hypomagnesemia in
case reports and hospital-based cohort studies. Our objective was to determine whether PPI …

The association between the long-term use of proton pump inhibitors (PPIs) and the risks of
various diseases remains controversial. Therefore, the primary objective of this study was to …

The availability of over-the-counter (OTC) proton pump inhibitors (PPIs) for the short-term (2
weeks) management of frequent heartburn (≥ 2 days/week) has increased markedly, yet …

Mechanisms and causes of hypomagnesemia : Current Opinion in Nephrology and
Hypertension Mechanisms and causes of hypomagnesemia : Current Opinion in …

Some things change. Much remains the same. Proton pump inhibitors (PPIs) continue to be
the mainstay of treatment of acid-related disease, especially gastroesophageal reflux …

Background Some evidence suggests that proton pump inhibitors (PPIs) are an under-
appreciated risk factor for hypomagnesemia. Whether hospitalization with hypomagnesemia …